Latest Investor Confidence News

BlueBet has announced a strategic acquisition of TopSport, supported by a $15 million equity raise, aiming to boost market share and deliver significant earnings accretion by FY26.

Centuria Office REIT (ASX:COF) reported solid HY25 results with a $1.9 billion portfolio and 92.2% occupancy, underpinned by active leasing and refinancing initiatives. Despite a dip in revenue and distributions, the REIT maintains its FY25 guidance, reflecting confidence in office market recovery and strategic asset management.

AKORA Resources has increased its placement by $25,000, bringing the total to $1.318 million as it advances strategic investor discussions and logistics planning following its Pre-Feasibility Study.

Betashares Mrtn Currie Real Income Fund (RINC) units were suspended from trading on the ASX on 4 February 2025, following a prior announcement in December 2024. This suspension marks a significant operational shift for the managed fund.

AKORA Resources has raised $1.293 million through a strategic share placement involving its first institutional investor and full board participation, aiming to advance logistics and investor discussions for its Bekisopa iron ore project.

AXP Energy has secured $1.25 million through a share placement to accelerate its modular data centre rollout powered by stranded natural gas in Colorado. This capital injection aims to support the company’s pioneering gas-to-power operations tied to Bitcoin mining and other high-performance computing applications.

Viridis Mining and Minerals Limited has been reinstated to ASX quotation following a capital raising announcement, ending its trading suspension and signaling renewed investor confidence.

Battery Age Minerals has successfully raised $1.5 million through a placement to advance its newly acquired El Aguila Project in Santa Cruz, aiming to unlock significant gold and silver potential.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

SEEK Limited’s proposed acquisition of Xref Limited has hit a major roadblock after Xref shareholders voted against the scheme, falling short of the required 75% approval threshold. Despite strong endorsements, the deal is now terminated, prompting SEEK to reconsider its growth strategy.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.

ARGO Investments Limited has updated its dividend distribution announcement, confirming a fully franked ordinary dividend of AUD 0.17 per share for the half-year ending December 2024 and correcting previous details on its Bonus Security Plan pricing.